Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Professor Moein Moghimi.

Newcastle AuthorsTitleYearFull text
Hajira Haroon
Professor Moein Moghimi
A brief history of long circulating nanoparticles2022
Professor Moein Moghimi
Antibody-Dependent Complement Responses toward SARS-CoV-2 Receptor-Binding Domain Immobilized on "Pseudovirus-Like" Nanoparticles2022
Professor Moein Moghimi
Cell medium-dependent dynamic modulation of size and structural transformations of binary phospholipid/ω-3 fatty acid liquid crystalline nano-self-assemblies: Implications in interpretation of cell uptake studies2022
Professor Moein Moghimi
Critical issues and pitfalls in serum and plasma handling for complement analysis in nanomedicine and bionanotechnology2022
Professor Moein Moghimi
Pro-inflammatory concerns with lipid nanoparticles2022
Professor Moein Moghimi
Complement opsonization of nanoparticles: Differences between humans and preclinical species2021
Professor Moein Moghimi
Dendrimer end-terminal motif-dependent evasion of human complement and complement activation through IgM hitchhiking2021
Professor Moein Moghimi
Editorial: Immune Mechanisms in the Pathologic Response to Particles, Fibers, and Nanomaterials2021
Professor Moein Moghimi
Integrin-Targeted, Short Interfering RNA Nanocomplexes for Neuroblastoma Tumor-Specific Delivery Achieve MYCN Silencing with Improved Survival2021
Rach Dixon
Dr Wing Man Lau
Dr Philip Manning
Professor Mark Birch-Machin
Professor Moein Moghimi
et al.
Microneedle-based devices for point-of-care infectious disease diagnostics2021
Professor Moein Moghimi
Roadmap on nanomedicine2021
Professor Moein Moghimi
A rally for brain targeting: the advent of a new era2020
Professor Moein Moghimi
Airborne Particulate Matter and SARS-CoV-2 Partnership: Virus Hitchhiking, Stabilization and Immune Cell Targeting — A Hypothesis2020
Professor Moein Moghimi
Complement activation by drug carriers and particulate pharmaceuticals: Principles, challenges and opportunities2020
Professor Moein Moghimi
Hexosome engineering for targeting of regional lymph nodes2020
Professor Moein Moghimi
Overcoming nanoparticle-mediated complement activation by surfaces PEG pairing2020
Rach Dixon
Dr Wing Man Lau
Professor Moein Moghimi
Dr Keng Wooi Ng
The diagnostic potential of microneedles in infectious diseases2020
Professor Moein Moghimi
Tuning the Engines of Nanomedicine2020
Professor Moein Moghimi
CAR T-cell bioengineering: Single variable domain of heavy chain antibody targeted CARs2019
Professor Moein Moghimi
Combined Fluorimetric Caspase-3/7 Assay and Bradford Protein Determination for Assessment of Polycation-Mediated Cytotoxicity2019
Professor Moein Moghimi
Complement therapeutics meets nanomedicine: overcoming human complement activation and leukocyte uptake of nanomedicines with soluble domains of CD552019
Dr Linping Wu
Professor Moein Moghimi
Crossing the blood-brain-barrier with nanoligand drug carriers self-assembled from a phage display peptide2019
Professor Moein Moghimi
Determination of Polycation-Mediated Perturbation of Mitochondrial Respiration in Intact Cells by High-Resolution Respirometry (Oxygraph-2k, OROBOROS)2019
Professor Moein Moghimi
Erratum to: Immunoglobulin deposition on biomolecule corona determines complement opsonization efficiency of preclinical and clinical nanoparticles (Nature Nanotechnology, (2019), 10.1038/s41565-018-0344-3)2019
Professor Moein Moghimi
Immunoglobulin deposition on biomolecule corona determines complement opsonization efficiency of preclinical and clinical nanoparticles2019
Professor Moein Moghimi
Lactate Dehydrogenase Assay for Assessment of Polycation Cytotoxicity2019
Professor Moein Moghimi
Non-Lamellar Liquid Crystalline Nanocarriers for Thymoquinone Encapsulation2019
Professor Moein Moghimi
On the issue of transparency and reproducibility in nanomedicine2019
Professor Moein Moghimi
Perturbation of mitochondrial bioenergetics by polycations counteracts resistance to BRAFE600 inhibition in melanoma cells2019
David Bourne
Professor Moein Moghimi
Pharmacokinetic analysis reveals limitations and opportunities for nanomedicine targeting of endothelial and extravascular compartments of tumours2019
Professor Moein Moghimi
Publisher Correction: On the issue of transparency and reproducibility in nanomedicine (Nature Nanotechnology, (2019), 14, 7, (629-635), 10.1038/s41565-019-0496-9)2019
Professor Moein Moghimi
Publisher Correction: On the issue of transparency and reproducibility in nanomedicine (Nature Nanotechnology, (2019), 14, 7, (629-635), 10.1038/s41565-019-0496-9)2019
Professor Moein Moghimi
Reprogramming the lymphocyte axis for advanced immunotherapy2019
Dr Linping Wu
Professor Moein Moghimi
C1q-Mediated Complement Activation and C3 Opsonization Trigger Recognition of Stealth Poly(2-methyl-2-oxazoline)-Coated Silica Nanoparticles by Human Phagocytes2018
Professor Moein Moghimi
Multivalent targeting and killing of HER2 overexpressing breast carcinoma cells with methotrexate-encapsulated tetra-specific non-overlapping variable domain heavy chain anti-HER2 antibody-PEG-liposomes: In vitro proof-of-concept2018
Professor Moein Moghimi
Nanomedicine safety in preclinical and clinical development: focus on idiosyncratic injection/infusion reactions2018
Professor Moein Moghimi
Nanoparticle transport pathways into tumors2018
Dr Keng Wooi Ng
Professor Moein Moghimi
Skin biosensing and bioanalysis: what the future holds2018
Professor Moein Moghimi
Targeting Biological Barriers: Turning a Wall into a Therapeutic Springboard2018
Professor Moein Moghimi
Translational gaps in animal models of human infusion reactions to nanomedicines2018
Professor Moein Moghimi
Bypassing adverse injection reactions to nanoparticles through shape modification and attachment to erythrocytes2017
Dr Linping Wu
Professor Moein Moghimi
Complement proteins bind to nanoparticle protein corona and undergo dynamic exchange in vivo2017
Professor Moein Moghimi
In Vitro and In Vivo Differences in Murine Third Complement Component (C3) Opsonization and Macrophage/Leukocyte Responses to Antibody-Functionalized Iron Oxide Nanoworms2017
Professor Moein Moghimi
Nanoparticles and innate immunity: new perspectives on host defence2017
Professor Moein Moghimi
Revealing Dynamics of Accumulation of Systemically Injected Liposomes in the Skin by Intravital Microscopy2017
Professor Moein Moghimi
An integrated assessment of morphology, size, and complement activation of the PEGylated liposomal doxorubicin products Doxil®, Caelyx®, DOXOrubicin, and SinaDoxosome2016
Professor Moein Moghimi
Platelet mimicry: The emperor's new clothes?2016
Professor Moein Moghimi
Soluble and immobilized graphene oxide activates complement system differently dependent on surface oxidation state2016
Professor Moein Moghimi
Citrem modulates internal nanostructure of glyceryl monooleate dispersions and bypasses complement activation: Towards development of safe tunable intravenous lipid nanocarriers2015
Professor Moein Moghimi
Dendrimers in Medicine: Therapeutic Concepts and Pharmaceutical Challenges2015
Professor Moein Moghimi
Differential Modulation of Cellular Bioenergetics by Poly(L -lysine)s of Different Molecular Weights2015
Professor Moein Moghimi
Dr Linping Wu
Insidious pathogen-mimicking properties of nanoparticles in triggering the lectin pathway of the complement system2015
Professor Moein Moghimi
Meet our Editorial Board member2015
Dr Linping Wu
Professor Moein Moghimi
Modulatory Effect of Human Plasma on the Internal Nanostructure and Size Characteristics of Liquid-Crystalline Nanocarriers2015
Dr Linping Wu
Professor Moein Moghimi
Modulatory Role of Surface Coating of Superparamagnetic Iron Oxide Nanoworms in Complement Opsonization and Leukocyte Uptake2015
Professor Ciara O'Sullivan
Professor Moein Moghimi
New platforms for multi-functional ocular lenses: Engineering double-sided functionalized nano-coatings2015
Professor Moein Moghimi
Polyethylenimine architecture-dependent metabolic imprints and perturbation of cellular redox homeostasis2015
Professor Moein Moghimi
Repeated intraperitoneal injections of liposomes containing phosphatidic acid and cardiolipin reduce amyloid-β levels in APP/PS1 transgenic mice2015
Professor Moein Moghimi
Cancer nanomedicine and the complement system activation paradigm: Anaphylaxis and tumour growth2014
Professor Moein Moghimi
Just so stories: The random acts of anti-cancer nanomedicine performance2014
Dr Linping Wu
Professor Moein Moghimi
Live-cell fluorescent microscopy platforms for real-time monitoring of polyplex-cell interaction: Basic guidelines2014
Professor Moein Moghimi
Mechanisms of complement activation by dextran-coated superparamagnetic iron oxide (SPIO) nanoworms in mouse versus human serum2014
Professor Moein Moghimi
Poly(3-hydroxybutyrate-co-R-3-hydroxyhexanoate) Nanoparticles with Polyethylenimine Coat as Simple, Safe, and Versatile Vehicles for Cell Targeting: Population Characteristics, Cell Uptake, and Intracellular Trafficking2014
Professor Moein Moghimi
Reciprocity in the developmental regulation of aquaporins 1, 3 and 5 during pregnancy and lactation in the rat2014
Professor Moein Moghimi
T cells expressing VHH-directed oligoclonal chimeric HER2 antigen receptors: Towards tumor-directed oligoclonal T cell therapy2014